Reuters logo
BRIEF-Sonoma Pharmaceuticals announces results from Sebuderm Gel study in treatment of Seborrheic Dermatitis
2017年3月16日 / 中午11点57分 / 6 个月前

BRIEF-Sonoma Pharmaceuticals announces results from Sebuderm Gel study in treatment of Seborrheic Dermatitis

March 16 (Reuters) - Sonoma Pharmaceuticals Inc

* Sonoma Pharmaceuticals announces results from Sebuderm™ gel study in treatment of Seborrheic Dermatitis

* IGA of efficacy improvement from baseline was 33% at day 14 and 52% at day 28 for the study Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below